Cubist Systematic Strategies, LLC Rhythm Pharmaceuticals, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$15.81 - $27.8 $1.27 Million - $2.23 Million	80,102 New	80,102 $1.84 Million
Q1 2023 May 15, 2023	BUY	$16.88 - $34.24 $4.43 Million - $8.98 Million	262,250 Added 1588.62%	278,758 $4.97 Million
Q4 2022 Feb 14, 2023	SELL	$22.21 - $30.25 $2.11 Million - $2.87 Million	-95,003 Reduced 85.2%	16,508 $480,000
Q3 2022 Nov 14, 2022	BUY	$4.3 - $30.85 $57,706 - $414,007	13,420 Added 13.68%	111,511 $2.73 Million
Q2 2022 Aug 15, 2022	BUY	$3.12 - $12.25 $306,043 - $1.2 Million	98,091 New	98,091 $407,000
Q1 2022 May 16, 2022	SELL	$6.13 - $12.24 $89,871 - $179,450	-14,661 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$8.62 - $13.9 $126,377 - $203,787	14,661 New	14,661 $146,000
Q4 2020 Feb 16, 2021	SELL	$21.17 - $32.61 $205,221 - $316,121	-9,694 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$18.13 - $30.61 $175,752 - $296,733	9,694 New	9,694 $210,000
Q1 2020 May 15, 2020	SELL	$13.16 - $22.9 $183,174 - $318,745	-13,919 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$19.53 - $25.5 $89,193 - $116,458	4,567 Added 48.83%	13,919 $320,000
Q3 2019 Nov 14, 2019	SELL	$18.62 - $24.51 $60,887 - $80,147	-3,270 Reduced 25.91%	9,352 $202,000
Q2 2019 Aug 14, 2019	BUY	$21.11 - $28.48 $266,450 - $359,474	12,622 New	12,622 $278,000
Q3 2018 Nov 14, 2018	SELL	$26.99 - $35.85 $235,757 - $313,149	-8,735 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$17.02 - $35.2 $128,654 - $266,076	7,559 Added 642.77%	8,735 $273,000
Q1 2018 May 15, 2018	SELL	$19.9 - $32.25 $36,138 - $58,566	-1,816 Reduced 60.7%	1,176 $23,000
Q4 2017 Feb 14, 2018	BUY	$22.0 - $30.51 $65,824 - $91,285	2,992	2,992 $87,000

Others Institutions Holding RYTM

# of Institutions

191

Shares Held

67.3M

Call Options Held

834K

Put Options Held

78.6K

Primecap Management CO Pasadena, CA

7.22M
Shares

$405 Million
0.28% of portfolio
Black Rock Inc. New York, NY

6.74M
Shares

$378 Million
0.01% of portfolio
Baker Bros. Advisors LP New York, NY

6.4M
Shares

$359 Million
3.59% of portfolio
Ra Capital Management, L.P. Boston, MA

6.08M
Shares

$341 Million
4.44% of portfolio
Goldman Sachs Group Inc New York, NY

3.88M
Shares

$218 Million
0.03% of portfolio

View Full List

About RHYTHM PHARMACEUTICALS, INC.

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.13B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

More about RYTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account